Maha Katabi's Net Worth

$407 Million

Estimate Recalculated Feb 28, 2024 04:47PM EST

Who is Maha Katabi?

Maha Katabi has an estimated net worth of $407 Million. This is based on reported shares across multiple companies, which include Vera Therapeutics, Inc., CinCor Pharma, Inc., Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., Akouos, Inc., and RayzeBio, Inc..

SEC CIK

Maha Katabi's CIK is 0001720685

Past Insider Trading and Trends

2021 was Maha Katabi's most active year for acquiring shares with 12 total transactions. Maha Katabi's most active month to acquire stocks was the month of May. 2021 was Maha Katabi's most active year for disposing of shares, totalling 4 transactions. Maha Katabi's most active month to dispose stocks was the month of January. 2021 saw Maha Katabi paying a total of $39,530,920.53 for 18,711,694 shares, this is the most they've acquired in one year. In 2022 Maha Katabi cashed out on 17,852,428 shares for a total of $85,920.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vera Therapeutics, Inc. (VERA) Snapshot price: $37.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.65%
161.29K
$31.00
$4,999,990.00
3.63M
Jan 30
Form 4
0
0
May 10
Form 4
+8.98%
285.71K
$7.00
$1,999,998.00
3.47M
Feb 6
Form 4
0
0
May 24
Form 4
+9.15%
266.67K
$15.00
$3,999,990.00
3.18M
Feb 10
Form 4
2.91M
$11.00
2.91M
May 18
Form 4
0
0
May 13
Form 3
0
0
No matching records found

No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.11M
$14.32
-$85,920.00
0
Nov 28 - Feb 24
Form 4
+8.97%
500K
$30.00
$15,000,000.00
6.07M
Aug 11
Form 4
5.57M
$16.00
5.57M
Jan 11
Form 3
0
0
No matching records found

Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $19.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 2
Form 4
0
0
Jun 6
Form 4
0
0
Jan 3
Form 4
0
0
Jun 21
Form 4
0
0
Jan 3
Form 4
3.76M
$14.00
3.76M
Jul 1 - Jul 2
Form 4
0
0
Feb 1 - Jun 29
Form 3
0
0
No matching records found

Inozyme Pharma, Inc. (INZY) Snapshot price: $5.36

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.03M
$16.00
2.03M
Jul 28
Form 3
0
0
No matching records found

Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $1.025

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.75M
$20.00
2.75M
Feb 9
Form 3
0
0
No matching records found